Cargando…
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
Autores principales: | Ling, Feng, Xu, Shengen, Li, Xiaochen, Sun, Xingwang, Long, Wenbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969661/ https://www.ncbi.nlm.nih.gov/pubmed/36849899 http://dx.doi.org/10.1186/s12885-023-10666-z |
Ejemplares similares
-
Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
por: Feng, Ling, et al.
Publicado: (2023) -
High-Expression of Cytoplasmic Poly (A) Binding Protein 1 (PABPC1) as a Prognostic Biomarker for Early-Stage Esophageal Squamous Cell Carcinoma
por: Pu, Jiangtao, et al.
Publicado: (2021) -
Targeting of the cytosolic poly(A) binding protein PABPC1 to mitochondria causes mitochondrial translation inhibition
por: Wydro, Mateusz, et al.
Publicado: (2010) -
Poly(A) tail length regulates PABPC1 expression to tune translation in the heart
por: Chorghade, Sandip, et al.
Publicado: (2017) -
Functional compensation for the loss of testis-specific poly(A)-binding protein, PABPC2, during mouse spermatogenesis
por: KASHIWABARA, Shin-ichi, et al.
Publicado: (2016)